Biotechnology

The End of Heart Disease

Over 610,000 Americans die of heart disease every year.

That’s 610,000 families torn apart… 610,000 parentless children… 610,000 lives taken away early.

Worldwide, the numbers get even more alarming…

An estimated 17.7 million people around the world died from cardiovascular diseases in 2015 alone.

And those numbers continue to climb, year after year.

But all of that devastation… the pain… the suffering…

It’s all about to be a thing of the past.

If you or a loved one is suffering from the symptoms of heart disease, that may soon be over.

Not only is this incredible news for anyone who’s had to deal with the devastation of heart disease…

But it could also hand you the retirement of your dreams.

Time and time again, I have been ahead of the biggest stories in the market.

And that’s why this is so exciting…

I truthfully never thought I’d live to see an opportunity of this magnitude.

After spending countless hours digging into the company, I’ve never been more excited about anything in my life…

If I’m right — as I’m certain I am — fortunes will be made starting as early as Oct. 31… and it’s all thanks to the man Forbes calls “the luckiest guy in the drug business.”

The No. 1 Seller in Pharmaceutical History

Statins are among the best-selling drugs in all pharmaceutical history.

Some 40 million people use statins in the United States alone, and some 220 million prescriptions are written yearly. A significant percentage of them could be helped by a new oral drug.

But statins alone aren’t always enough to lower blood cholesterol levels in patients. About 13 million Americans have cardiovascular disease that can’t be treated with statins alone

A convenient, once-a-day pill would be a much more popular (and profitable) option for patients who need additional control or need to avoid statin drugs altogether.

So far the company behind this drug has already racked up an impressive number of successes in clinical trials.

And that’s just the United States. There’s an entire world out there that could use this drug too.

The small biotech behind things is in the race to enter one of the biggest pharmaceutical markets of all time.

Oct. 31st — The Day Your Wealth Changes Forever

After developing this drug for years, running extensive clinical trials (with results that have stunned the medical community), giving hope to families all around the country, passing through all of the FDA’s rigid phases of clinical testing to approve a new drug…

We’re just moments away from a potential application for a new drug application (NDA).

The company bringing this new drug to the millions of people who need it opens up an untapped $129.2 billion market.

That’s why Oct. 31 is so important. Because although I’ve been following this story for years, NOW is the time to get in.

As early as Oct. 31, this company will stun the world as they go public with clinical trial results of the treatment that will give hope to millions.

And, as soon as they do, they’ll prepare to file a New Drug Application.

Mark the calendar for Oct. 31.

But the fastest movers can click here now and get in today.

For Technology Profits Daily,

Ray Blanco
Chief Technology Expert, Technology Profits Daily

You May Also Be Interested In:

Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco